Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
AI plays a crucial role in identifying early-stage cancers, facilitating prompt interventions that enhance survival prospects. Cancer's intricate nature means that each type carries distinct characteristics, packed with extensive data that requires thorough analysis. This is where AI excels, leveraging its capabilities to process complex information, ultimately revealing insights that can significantly aid in cancer treatment strategies. Equipped with precise and relevant data, we take proactive steps in our battle against cancer. By utilizing AI, we are poised to make substantial strides in overcoming this disease. Our AI technology is designed to detect early-stage cancer with remarkable accuracy, achieving detection rates between 97-99%. It proficiently identifies ten of the most prevalent abnormalities found in chest x-rays, thus enhancing one of the most fundamental diagnostic tools. This innovation not only streamlines the radiology workflow but also alleviates the workload for radiologists. Lunit INSIGHT CXR successfully encompasses a wide range of findings, ensuring that we are prepared to tackle the challenges presented by cancer detection and treatment. The future of cancer care looks promising with AI at the forefront of these advancements.
Description
Accelerating the speed, precision, and affordability of cancer diagnoses is crucial, especially considering that one in three individuals will face this disease in their lifetime. Unfortunately, the current diagnostic process is often hindered by slow and costly methods, primarily due to the lack of advanced automated tools that support healthcare professionals. Qritive addresses this challenge by offering an AI-driven solution designed to assist physicians in analyzing both microscopy images and textual patient data efficiently. This innovation not only enhances the effectiveness of hospitals in diagnosing cancer but also contributes to significant cost savings. Additionally, Pantheon serves as a CE-marked, vendor-agnostic digital pathology platform that facilitates the complete digitization of pathology lab workflows and telepathology. It also supports comprehensive report generation and offers a robust platform for AI-driven analysis of whole-slide images in pathology. This technology is particularly adept at distinguishing between a variety of benign conditions and malignant diseases within breast tissue, which is vital for timely and accurate treatment. In doing so, it plays a pivotal role in transforming the landscape of cancer diagnostics.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Lunit
Country
United States
Website
www.lunit.io/en
Vendor Details
Company Name
Qritive
Founded
2017
Country
Singapore
Website
www.qritive.com